🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are champions! Again!! 🇦🇷🇦🇷🇦🇷

FLoscoMD Fabián YABER, MD PhD Federico Ferraris Michael Hofman Ken Herrmann Danny Mena - nuclear medicine Julian G. Rojas James Buteau Osvaldo Garcia Cecilia Carreras Juan Pablo Sade Maite Bourlon Ray Manneh Kopp Mauricio Fernandez L Daniel Castellano Martín Angel Diego Barreiro DR CARVAJAL Declan Murphy Hector Manuel Sanchez Lopez Ramon Coronil Pablo CASTRO PEÑA

⚡️ EVITA (EV Ineligible criTeriA) criteria for identifying patients ineligible for the EV/Pembro combo in #metastaticurothelialcarcinoma 👉To identify patients who may not be optimal candidates for EV/P if they meet at least two of the following criteria: 🩺 🔹Hemoglobin A1c

1/ Results from #LITESPARK-005 are out NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) U.S. FDA approval Dec 2023 in pretreated pts w/ #ccRCC. Presentation #ESMO24 @myEsmo Check it out: nejm.org/doi/full/10.10…

Confederación Americana de Urología (CAU) y UroTeragLATAM juntos para promover la educación PSMA en LATAM. Era JORNADA: “EL FUTURO CON PSMA” ✔️ GRATIS ✔️ MULTIDISCIPLINARIO 👇👇👇 Daniel Castellano Diego Barreiro Federico Ferraris Declan Murphy Mauricio Fernandez L Danny Mena - nuclear medicine

Excellent contribution to the knowledge of UC biology in LATAM. Thanks to the LACOG - Latin American Cooperative Oncology Group for allowing me to participate. sciencedirect.com/science/articl…

We miss you Tom Powles & Toni Choueiri, MD. Christopher Sweeney, MBBS is happy with the argentinians! 🇦🇷🇦🇷

Estamos cerca. UroTarget 2024 / 31 Oct-2 Nov. Mendoza, ARG Asociación Argentina de Oncología Clínica (AAOC) UroTarget

Preceptorship en Cáncer de Próstata en Fundación COIR con toda la unidad de Uro-oncología. Excelente jornada junto a colegas de otras provincias!! Laura Pelagatti Mariano Nuñez Román Oberti

Falta muy poco para los 9 años de ⁦UroTarget⁩. El gran ⁦Andrey Soares⁩ estará con nosotros para continuar creciendo en #LATAM. ⁦LACOG - Latin American Cooperative Oncology Group⁩ ⁦Asociación Argentina de Oncología Clínica (AAOC)⁩ ⁦blatam uro⁩

We are ready to see this and the rest of the advances in uro-oncology from the best at UroTarget 2024. Daniel Castellano FLoscoMD Danny Mena - nuclear medicine Tom Powles Juan Pablo Sade Martín Angel @aaoc UroTarget

Espectacular actividad junto a Urólogos y Oncólogos Clínicos compartiendo experiencias y conocimientos en Cáncer de Próstata y Urotelial en Fundación COIR. Gracias J&J! Laura Pelagatti Mariano Nuñez UroTarget

⁦UroTarget⁩ 2024 #Mendoza 🇦🇷 🙌Engaging academic discussions and unforgettable moments with amazing people. Thank you! ⁦Daniel Castellano⁩ ⁦David Olmos⁩ ⁦Tom Powles⁩ ⁦UroTeragLATAM⁩ ⁦LACOG - Latin American Cooperative Oncology Group⁩ ⁦Asociación Argentina de Oncología Clínica (AAOC)⁩ ⁦ASCO⁩

Wonderful moments with Friends - 𝕌𝕣𝕠𝕋𝕒𝕣𝕘𝕖𝕥 𝟚𝟘𝟚𝟜 - FLoscoMD Danny Mena - nuclear medicine Daniel Castellano Tom Powles Juan Pablo Sade David Olmos UroTarget

Hypnotized by Tom 𝕌𝕣𝕠𝕋𝕒𝕣𝕘𝕖𝕥 𝟚𝟘𝟚𝟜 Tom Powles Daniel Castellano Mauricio Fernandez L Juan Pablo Márquez Lara

what is UroTarget ??? is....... this👇

Big news👋. A positive R3 trial for PD-1 in NMIBC! The CREST trial evaluated sasanlimab (PD-1i)+BCG vs Standard BCG (induction and maintenance) in BCG-naïve, high-risk NMIBC.The study met its primary endpoint of EFS with ‘clinically meaningful’ results. pfizer.com/news/press-rel…

Save the Date! 𝟭𝟬 𝘆𝗲𝗮𝗿𝘀 𝗲𝗱𝗶𝘁𝗶𝗼𝗻 6-8 Nov 2025 / Mendoza, Arg Asociación Argentina de Oncología Clínica (AAOC)

Festejo de cumpleaños del "hombre más interesante del mundo", Prof Levin Martínez UroTarget TEAM FLoscoMD Gustavo Villoldo Juan Camean ceciatencio

With the most interesting man of the world, Prof Levin Martinez. Cheers Toni Choueiri, MD & Daniel Castellano🍷🍷